申请人:TAKEDA PHARMACEUTICALS CO
公开号:WO2018100558A2
公开(公告)日:2018-06-07
The present disclosure provides a compound having a STING agonistic activity, which may be expected to be useful as an agent for the prophylaxis or treatment of STING-related diseases. The present disclosure relates to a compound represented by the formula (I), wherein each symbol is as defined in the description, or a salt thereof.